endometriosis ovarian cancer risk association reply, Schliep Barnard Peterson endometriosis cancer correspondence, endometriosis malignant transformation ovarian cancer JAMA, endometriosis ovarian cancer epidemiological evidence, endometriosis cancer risk long-term outcomes, ovarian cancer gynecologic conditions endometriosis link, endometriosis comorbidity ovarian malignancy risk, endometriosis histological subtypes ovarian cancer relationship
PMID 39621324 39621324 DOI 10.1001/jama.2024.21911 10.1001/jama.2024.21911
Cite this article
Schliep, K. C., Barnard, M. E., & Peterson, C. M. (2024). Endometriosis and Ovarian Cancer-Reply. *JAMA*, *332*(24), 2117-2118. https://doi.org/10.1001/jama.2024.21911
Schliep KC, Barnard ME, Peterson CM. Endometriosis and Ovarian Cancer-Reply. JAMA. 2024;332(24):2117-2118. doi:10.1001/jama.2024.21911
Schliep, K. C., et al. "Endometriosis and Ovarian Cancer-Reply." *JAMA*, vol. 332, no. 24, 2024, pp. 2117-2118.
Infertility affects 1 in 6 people globally (and up to a third of physicians) and is recognized by the World Health Organization and the American Medical Association as a disease. Since 1978, the devel...
NaProTECHNOLOGY > Debate and Controversy > Critique of RRMEthics/Philosophy > Medical Ethics > Access to Fertility TreatmentRRM Methods > Debate and Controversy > Evidence Evaluation
Importance: Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-descri...
Endometriosis > Long-Term Outcomes > Cancer RiskEndometriosis > Classification > Typology and PrognosisGeneral OB/GYN > Gynecological Cancer > Endometriosis-Associated
Importance: Dietary supplements marketed for male fertility commonly contain folic acid and zinc based on limited prior evidence for improving semen quality. However, no large-scale trial has examined...